Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study

Peptic Ulcer Bleeding Clinical Trial

— KPUB  

Official title:

Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02152904
• Other study ID #: KPUB
• Status: Completed
• Phase: N/A
• First received: May 29, 2014
• Last updated: August 3, 2016
• Start date: April 2014
• Est. completion date: March 2016

Study information

• Verified date: August 2016
• Source: Incheon St.Mary's Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: National Strategic Coordinating Center for Clinical Research
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of the investigators study is to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding.

Description:

The investigators are performing a nationwide population based cohort study to investigate the factors associated with rebleeding in patients with peptic ulcer bleeding. The results of the investigators study should give us information about patients who are at high risk of rebleeindg and enable us to manage these patients appropriately.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 892
• Est. completion date: March 2016
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 85 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed with peptic ulcer bleeding by endoscopy

• Patients who consent to be enrolled in the study

Exclusion Criteria:

• Patients who refuse to be enrolled in the study

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hemorrhage
• Peptic Ulcer
• Peptic Ulcer Bleeding
• Peptic Ulcer Hemorrhage
• Ulcer

Locations

Country	Name	City	State
Korea, Republic of	Incheon St. Mary's Hospital	Incheon

Sponsors (1)

Lead Sponsor	Collaborator
Joon Sung Kim

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rebleeding rate of peptic ulcer bleeding	The rebleeding rate of patients diagnosed with peptic ulcer ble4eding	1 year	No
Secondary	Mortality rates of peptic ulcer bleeding	The 30 day mortality rate of patients diagnosed with peptic ulcer bleeding	30 days	No